Plasma Technology Offers Breathable Air in Biological and Chemical Threat Situations

Article

RICHLAND, Wash. Pacific Northwest National Laboratory researchers are using the universe's most common form of matter, plasma, in a new filtration system that may one day save the lives of people seeking shelter from chemical or biological attacks.

 

Originally designed for the Department of Defense to protect soldiers, PNNL's Hybrid Plasma Filtration System may soon find a niche in the commercial market as well. The laboratory has built a compact prototype of the system, but plans to enlarge it significantly for use in bigger spaces, such as buildings, tented structures and aircraft.

 

"This is a technology that we wish the nation wouldn't need, but in light of our changing times, it's satisfying to be part of a solution that can help protect people and even save lives," said Ken Rappe, PNNL's senior development engineer.

 

PNNL's filtration system is unlike any other because it doesn't use common High Efficiency Particulate Air, or HEPA, filters. Instead, researchers found that by using plasma to destroy airborne contaminants that come through the filters, they actually lasted much longer, making the system more reliable and less cumbersome to operate.

 

In addition, the PNNL-developed system is able to destroy both biological and chemical contaminants including toxic industrial chemicals, such as hydrogen cyanide and hydrochloric acid, and chemical warfare agents, such as sarin, which was released in a 1995 terrorist attack in the Tokyo subway.

 

In addition to destroying potentially deadly agents, the system pumps out purified air, allowing people to breathe freely in an otherwise contaminated environment.

 

PNNL (www.pnl.gov) is a DOE Office of Science laboratory that solves complex problems in energy, national security, the environment and life sciences by advancing the understanding of physics, chemistry, biology and computation. PNNL employs 3,900, has a $650 million annual budget, and has been managed by Ohio-based Battelle since the lab's inception in 1965.

 

Source: Pacific Northwest National Laboratory

Related Videos
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today Topic of the Month: Mental Health
Related Content